NO20011117L - Anvendelse av benzensulfonyl(tio)ureaforbindelser for behandling og forebygging av dysfunksjoner i det autonomerenervesystem og anvendelse av benzensulfonyl(tio)ureaforbindelser ikombinasjon med <beta>-reseptor-blokkere - Google Patents
Anvendelse av benzensulfonyl(tio)ureaforbindelser for behandling og forebygging av dysfunksjoner i det autonomerenervesystem og anvendelse av benzensulfonyl(tio)ureaforbindelser ikombinasjon med <beta>-reseptor-blokkereInfo
- Publication number
- NO20011117L NO20011117L NO20011117A NO20011117A NO20011117L NO 20011117 L NO20011117 L NO 20011117L NO 20011117 A NO20011117 A NO 20011117A NO 20011117 A NO20011117 A NO 20011117A NO 20011117 L NO20011117 L NO 20011117L
- Authority
- NO
- Norway
- Prior art keywords
- benzenesulfonyl
- thio
- urea compounds
- autonomer
- dysfunctions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/54—Silicon-containing compounds
- C08K5/5406—Silicon-containing compounds containing elements other than oxygen or nitrogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1998141534 DE19841534A1 (de) | 1998-09-10 | 1998-09-10 | Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung und Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern |
| DE1999101061 DE19901061A1 (de) | 1999-01-14 | 1999-01-14 | Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung von Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern |
| PCT/EP1999/006450 WO2000015204A2 (en) | 1998-09-10 | 1999-09-02 | Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20011117D0 NO20011117D0 (no) | 2001-03-05 |
| NO20011117L true NO20011117L (no) | 2001-05-02 |
| NO330215B1 NO330215B1 (no) | 2011-03-07 |
Family
ID=26048790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011117A NO330215B1 (no) | 1998-09-10 | 2001-03-05 | Anvendelse av benzensulfonyl(tio)ureaforbindelser,produkt og farmasoytisk preparat omfattende ±n eller flere slike forbindelser |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6414030B1 (no) |
| EP (1) | EP1117409B1 (no) |
| JP (1) | JP4733268B2 (no) |
| KR (1) | KR100981592B1 (no) |
| CN (1) | CN1195524C (no) |
| AR (1) | AR020411A1 (no) |
| AT (1) | ATE287718T1 (no) |
| AU (1) | AU762832B2 (no) |
| BR (1) | BR9913572A (no) |
| CA (1) | CA2343009C (no) |
| CZ (1) | CZ301165B6 (no) |
| DE (1) | DE69923464T2 (no) |
| DK (1) | DK1117409T3 (no) |
| ES (1) | ES2235507T3 (no) |
| HK (1) | HK1040187B (no) |
| HU (1) | HU228988B1 (no) |
| ID (1) | ID28854A (no) |
| IL (2) | IL141414A0 (no) |
| MY (1) | MY121798A (no) |
| NO (1) | NO330215B1 (no) |
| NZ (1) | NZ510424A (no) |
| PL (1) | PL194986B1 (no) |
| PT (1) | PT1117409E (no) |
| RU (1) | RU2247562C2 (no) |
| TR (1) | TR200100692T2 (no) |
| TW (1) | TWI238817B (no) |
| WO (1) | WO2000015204A2 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19917233A1 (de) * | 1999-04-16 | 2000-10-19 | Aventis Pharma Gmbh | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
| DE19923086A1 (de) | 1999-05-20 | 2000-11-23 | Aventis Pharma Gmbh | Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| US7620611B1 (en) * | 1999-07-20 | 2009-11-17 | Trilithic, Inc. | Neural networks for ingress monitoring |
| DE10054481A1 (de) * | 2000-11-03 | 2002-05-08 | Aventis Pharma Gmbh | Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE10054482A1 (de) | 2000-11-03 | 2002-05-08 | Aventis Pharma Gmbh | Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE10129704A1 (de) * | 2001-06-22 | 2003-01-02 | Aventis Pharma Gmbh | Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks |
| CN1330630C (zh) * | 2004-03-10 | 2007-08-08 | 中国药科大学 | 新的磺酰(硫)脲衍生物、其制备方法及含有它们的药物组合物 |
| DE102004061017A1 (de) | 2004-12-18 | 2006-06-22 | Sanofi-Aventis Deutschland Gmbh | Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| MX2009012644A (es) * | 2007-06-05 | 2009-12-10 | Sanofi Aventis | Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1185180B (de) * | 1963-10-19 | 1965-01-14 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
| DE1518874C3 (de) * | 1964-10-07 | 1975-03-13 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung |
| DE3009047A1 (de) | 1980-03-08 | 1981-09-24 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue l-(acylamino-aryloxy-)2-hydroxy-3-alkinylaminopropane und verfahren zu ihrer herstellung |
| GB8716972D0 (en) * | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Treatment of cardiac arrhythmias |
| ES2098069T3 (es) | 1993-02-23 | 1997-04-16 | Hoechst Ag | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos. |
| DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| WO1996028437A1 (en) | 1995-03-10 | 1996-09-19 | Hoechst Marion Roussel, Inc. | Novel process for preparing 2,3-dihydro-benzofuranol derivatives |
| FR2746013B1 (fr) | 1996-03-18 | 1998-05-29 | Sanofi Sa | Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus |
-
1999
- 1999-09-02 CZ CZ20010858A patent/CZ301165B6/cs not_active IP Right Cessation
- 1999-09-02 RU RU2001109434/15A patent/RU2247562C2/ru not_active IP Right Cessation
- 1999-09-02 BR BR9913572-8A patent/BR9913572A/pt not_active Application Discontinuation
- 1999-09-02 ID IDW20010566A patent/ID28854A/id unknown
- 1999-09-02 PT PT99944585T patent/PT1117409E/pt unknown
- 1999-09-02 WO PCT/EP1999/006450 patent/WO2000015204A2/en active IP Right Grant
- 1999-09-02 EP EP99944585A patent/EP1117409B1/en not_active Expired - Lifetime
- 1999-09-02 DE DE69923464T patent/DE69923464T2/de not_active Expired - Lifetime
- 1999-09-02 TR TR2001/00692T patent/TR200100692T2/xx unknown
- 1999-09-02 HU HU0103534A patent/HU228988B1/hu not_active IP Right Cessation
- 1999-09-02 NZ NZ510424A patent/NZ510424A/xx not_active IP Right Cessation
- 1999-09-02 CN CNB998107794A patent/CN1195524C/zh not_active Expired - Fee Related
- 1999-09-02 PL PL347215A patent/PL194986B1/pl unknown
- 1999-09-02 AT AT99944585T patent/ATE287718T1/de active
- 1999-09-02 JP JP2000569788A patent/JP4733268B2/ja not_active Expired - Fee Related
- 1999-09-02 KR KR1020017003067A patent/KR100981592B1/ko not_active IP Right Cessation
- 1999-09-02 DK DK99944585T patent/DK1117409T3/da active
- 1999-09-02 IL IL14141499A patent/IL141414A0/xx active IP Right Grant
- 1999-09-02 ES ES99944585T patent/ES2235507T3/es not_active Expired - Lifetime
- 1999-09-02 AU AU57444/99A patent/AU762832B2/en not_active Ceased
- 1999-09-02 CA CA2343009A patent/CA2343009C/en not_active Expired - Fee Related
- 1999-09-08 AR ARP990104515A patent/AR020411A1/es not_active Application Discontinuation
- 1999-09-09 MY MYPI99003906A patent/MY121798A/en unknown
- 1999-11-25 TW TW088115446A patent/TWI238817B/zh not_active IP Right Cessation
-
2001
- 2001-02-13 IL IL141414A patent/IL141414A/en not_active IP Right Cessation
- 2001-03-05 NO NO20011117A patent/NO330215B1/no not_active IP Right Cessation
- 2001-11-09 US US09/986,626 patent/US6414030B1/en not_active Expired - Lifetime
-
2002
- 2002-02-26 HK HK02101438.6A patent/HK1040187B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO963776D0 (no) | (4,4-Difluorbut-3-enyltio)-substituerte heterosykliske eller karbocykliske ringforbindelser med disinfiserende virkning | |
| HUP0004557A3 (en) | Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors and pharmaceuticals containing the same | |
| EE200000706A (et) | Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid | |
| EE200100479A (et) | Kasvuhormooni nõristitena kasulikud heterotsüklilised aromaatsed ühendid ja nende kasutamine | |
| EP1066039A4 (en) | SUBSTITUTED QUINAZOLINE AND THEIR ANALOGS AND USES | |
| ATE273301T1 (de) | Substituierte aza- und diazacycloheptan- und - cyclooctanverbindungen und deren verwendung | |
| DE69909436D1 (de) | Isothioncyanat-Tolane und sie enthaltende flüssigkristalline Gemische | |
| DE69916742D1 (de) | Polybenzoxazol-Harz und dessen Vorstufe | |
| GB9809143D0 (en) | Triazine compounds and their use | |
| NO20011117L (no) | Anvendelse av benzensulfonyl(tio)ureaforbindelser for behandling og forebygging av dysfunksjoner i det autonomerenervesystem og anvendelse av benzensulfonyl(tio)ureaforbindelser ikombinasjon med <beta>-reseptor-blokkere | |
| DE60021507D1 (de) | Uracilverbindungen und deren Verwendung | |
| EE03682B1 (et) | Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine | |
| NO20013409D0 (no) | Anvendelse av pyrimidin-derivater for forhindring og behandling av cerebral ischemi | |
| DE69917777D1 (de) | Benzazol-verbindungen und ihre verwendung | |
| ATE212346T1 (de) | 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung | |
| EE200000391A (et) | Triasiiniühendid kesknärvisüsteemihäirete raviks | |
| NO983089D0 (no) | 2-amino-5,6-diklorbenzimidazol-derivater med antiviral aktivitet | |
| DE59902692D1 (de) | Phosphororganische verbindungen und ihre verwendung | |
| DE59906907D1 (de) | Phosphororganische verbindungen und ihre verwendung | |
| ATE236905T1 (de) | 4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indol-1- carboxamid-derivate, ihre herstellung und therapeutische verwendung | |
| EP1137412A4 (en) | SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUNDS AND THEIR THERAPEUTIC USE | |
| DE60036885D1 (de) | Succinimidverbindungen und deren verwendung | |
| DE69707363T2 (de) | 1,2,3-Benzothiadiazolderivate und ihre Verwendung als Mikrobizide | |
| GB9824160D0 (en) | Heterocyclic compounds and their therapeutic use | |
| IL144145A0 (en) | Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |